Pyrazoles as human non-pancreatic secretory phospholipase A2 inhibitors

摘要

A class of novel pyrazoles is disclosed together with the use of such compounds for inhibiting sPLA2 mediated release of fatty acids for treatment of conditions such as septic shock.